Vitamin B12 or folate Hemolytic uremic deficiency syndrome (HUS) Hepatocellular insufficiency: decreased PT, aPTT, decreased factors II, VII, X Immune thrombocytopenic and factor V, fibrinogen purpura (ITP) decreased. Evans syndrome Vitamin K deficiency: Dysimmune pancytopenia decreased PT, aPTT, factors Thrombotic of the vitamin K-dependent Abnormal microangiopathy (MAT): consumption: II, VII, IX, X, hemostasis Thrombotic proteins C and S; Factor V is thrombocytopenic purpura normal (TTP) DIC: decreased PT, APTT Hemolytic uremic prolongation, syndrome (HUS) thrombocytopenia, Acquired hemophilia A hypofibrinogenemia, reduction of factors V, PDF and increased D-dimer. tumor compression Cancer relapse Endovascular Tumor Antiphospholipids progression Thrombosis antibody syndrome Heparin-induced (APLS) thrombocytopenia Iatrogeny due to other drugs (revlimid, bortezomib) Tumor obstruction Dysimmune nephropathy Renal toxicity related to Thrombotic Elevated serum intercurrent medicines, an thrombocytopenic purpura Renal creatinine iodinated contrast agent (TTP) injection Hemolytic uremic Tumor lysis syndrome syndrome (HUS) Deficiency of potassium intake: anorexia, vomiting, taking laxatives, diuretics, Dysimmune nephropathy Hypokalemia exclusive artificial nutrition Colitis, autoimmune Excess extrarenal losses: enterocolitis Acute diarrhea, digestive fistulas SiADH due to tumor in lung, Dysimmune nephropathy brain Dysimmune colitis, … Iatrogenic: diuretics, dysimmune enterocolitis potomania Dysimmune Hyponatremia Excess of hypotonic hypothyroidism perfusions Dysimmune adrenal failure False hyponatremia: (central or peripheral) hyperglycemia Dysimmune diabetes …
Vitamin B12 or folate deficiency Hemolytic uremic syndrome (HUS) Abnormal hemostasis Hepatocellular insufficiency: decreased PT, aPTT, decreased factors II, VII, X and factor V, fibrinogen decreased. Vitamin K deficiency: decreased PT, aPTT, factors of the vitamin K-dependent consumption: II, VII, IX, X, proteins C and S; Factor V is normal DIC: decreased PT, APTT prolongation, thrombocytopenia, hypofibrinogenemia, reduction of factors V, PDF and increased D-dimer. Immune thrombocytopenic purpura (ITP) Evans syndrome Dysimmune pancytopenia Thrombotic microangiopathy (MAT): Thrombotic thrombocytopenic purpura (TTP) Hemolytic uremic syndrome (HUS) Acquired hemophilia A Thrombosis tumor compression Cancer relapse Endovascular Tumor progression Heparin-induced thrombocytopenia Iatrogeny due to other drugs (revlimid, bortezomib) Antiphospholipids antibody syndrome (APLS) Renal Elevated serum creatinine Tumor obstruction Renal toxicity related to intercurrent medicines, an iodinated contrast agent injection Tumor lysis syndrome Dysimmune nephropathy Thrombotic thrombocytopenic purpura (TTP) Hemolytic uremic syndrome (HUS) Hypokalemia Deficiency of potassium intake: anorexia, vomiting, taking laxatives, diuretics, exclusive artificial nutrition Excess extrarenal losses: Acute diarrhea, digestive fistulas Dysimmune nephropathy Colitis, autoimmune enterocolitis Hyponatremia SiADH due to tumor in lung, brain … Iatrogenic: diuretics, potomania Excess of hypotonic perfusions False hyponatremia: hyperglycemia … Dysimmune nephropathy Dysimmune colitis, dysimmune enterocolitis Dysimmune hypothyroidism Dysimmune adrenal failure (central or peripheral) Dysimmune diabetes
Immuuntherapie%20met%20anti-PD%20en%20de%20bijwekrkngen.docx